Cerluten is a brain-targeting peptide bioregulator designed to support CNS tissue function through epigenetic modulation of neuronal gene expression. It represents the Khavinson approach to neuroprotection — using tissue-specific short peptides to restore youthful gene expression patterns.
Research Applications
Cognitive aging, neuroprotection, post-stroke recovery support, neurodegenerative disease models, and CNS tissue maintenance.
Dosage Information (Research Use)
Oral capsules: 1-2 capsules daily for 10-30 day courses. Injectable: 10 mg/day for 10-day courses. Research use only.
Reconstitution & Handling
Capsules taken orally. Injectable form: standard BAC water reconstitution.
Half-Life & Pharmacokinetics
Short — typical of small peptide bioregulators.
Reported Observations in Literature
Generally well-tolerated in published research. No significant adverse effects reported.
Key Research References
- Khavinson VK. “Peptide regulation of gene expression and protein synthesis in aging.” Bull Exp Biol Med. 2007